Spironolactone and endocrine dysfunction

D. L. Loriaux, R. Menard, A. Taylor, R. andSanten

Research output: Contribution to journalArticlepeer-review

118 Scopus citations


Therapy with spironolactone is often associated with estrogenlike side effects, including impotence and gynecomastia in men and menstrual irregularity in women. Several possible mechanisms by which spironolactone could cause these side effects have been identified. Spironolactone has been shown to affect both gonadal and adrenal steroidogenesis, to elevate plasma gonadotrophin levels in children, and to act as an antiandrogen at the target tissue level. This conference presents a discussion of how these effects might interact to produce the endocrine side effects associated with spironolactone therapy.

Original languageEnglish (US)
Pages (from-to)630-636
Number of pages7
JournalAnnals of internal medicine
Issue number5
StatePublished - Jan 1 1976
Externally publishedYes

ASJC Scopus subject areas

  • Internal Medicine


Dive into the research topics of 'Spironolactone and endocrine dysfunction'. Together they form a unique fingerprint.

Cite this